Press Release: CMG and Oxaliplatin studies for colon cancer

Jul 26, 2021

1 min read

Updated: Aug 11, 2021

Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer.

Recent Posts

See All

A new research article on the high bioavailability of curcuRouge® has been published.

Our project has been selected for the AMED's “Research Project for Practical Application of Innovative Cancer Therapy”.

The article on information of research publication on curcuRouge® has been renewed.

Comments

A new research article on the high bioavailability of curcuRouge® has been published.

Our project has been selected for the AMED's “Research Project for Practical Application of Innovative Cancer Therapy”.